(As of May. 1,2021)


Japanese

(3)Advanced Medical and Dental Treatment

Items Date Initiated
Concurrent therapy with intravenous pemetrexed and cisplatin administration Lung Cancer(Only cases judged to have been completely excised pathologically excluding squamous lung cancer and small cell lung cancer) Sep.1,2012
Percutaneous radiofrequency ablation(RFA)(Breast cancer) Aug.1,2013
A multicenter randomized phase Ⅲ study for recurrent glioblastoma comparing bevacizumab alone with dose-dense temozolomide followed by bevacizumab (JCOG1308C, RE-GEND-pⅢ) Jan.1,2018
MRI/Ultrasound Fusion Prostate Biopsy(Patients with suspected prostate cancer) Oct.1,2019
hydorgen inhalation therapy May.1,2020
Percutaneous cryoablation for tuberous sclerosis-associated renal angiomyolipoma Oct.1,2020
Ethanol injection therapy for patients with pancreatic neuro endocrine neoplasm Oct.1,2020
Tumor-Profiling Multiplex Gene Assay Panel This assay is available for patients with advanced recurrent solid tumors(limited to those for which there is no treatment, those for which standard treatment has been completed, or those for which standard treatment is scheduled to be completed) Dec.1,2020